Smart pills are ingestible devices with sensors for diagnostics, drug delivery, and real-time health monitoring.

AUSTIN, TX, UNITED STATES, May 23, 2025 /EINPresswire.com/ -- The Global Smart Pills Market is undergoing a transformation, fueled by technology improvements and rising demand for non-invasive diagnostic and treatment options. According to latest industry data, the market is expected to grow at a 16% CAGR from 2024 to 2031.

Market Overview:

Smart pills, also known as ingestible sensors or digital pills, are revolutionizing healthcare by combining pharmaceuticals with electronics. These capsules, equipped with sensors and microchips, transmit data to external devices, enabling real-time monitoring of physiological conditions, medication adherence, and disease progression.

Download Sample Report Here: https://www.datamintelligence.com/download-sample/smart-pills-market

Market Drivers and Opportunities:

Here are the key factors driving the growth of the smart pill market:

Technological Advancements: Innovations in miniaturization, advanced sensors, wireless communication, artificial intelligence (AI), and energy harvesting have enhanced the capabilities of smart pills, making them more effective and user-friendly.

Rising Prevalence of Chronic Diseases: The increasing incidence of conditions such as gastrointestinal disorders, diabetes, and cardiovascular diseases necessitates continuous monitoring and personalized treatment, areas where smart pills excel.

Aging Population: The growing elderly population requires ongoing health management, and smart pills offer a non-invasive solution for monitoring and managing chronic conditions.

Demand for Non-Invasive Diagnostics: Patients and healthcare providers are increasingly favoring non-invasive diagnostic methods, which smart pills provide, over traditional procedures .

Market Segmentation:

By Product Type:
Capsule endoscopy
Drug delivery
Patient Monitoring

By Target Area:
Esophagus
Stomach
Small intestine
Large intestine
Others.

By Disease Indication:
Digestive Tract Diseases
Esophageal Diseases
Small Bowel Tumors
Colon Diseases
Others.

By End-User:
Hospitals
Diagnostic centers
Ambulatory surgical centers
Research Institutes.

By Region:
North America
Latin America
Europe
Asia Pacific
Middle East
Africa.

Geographical Market Share:

North America dominates the global market with a 37.5% share in 2023, owing to improved healthcare infrastructure, widespread acceptance of digital health technology, and a large patient base.

Asia Pacific is expected to develop at a CAGR of 12.7% during the forecast period, driven by rising demand for non-invasive procedures and the adoption of digital health technologies.

Key Market Players:

Prominent companies leading the smart pills market include:

Medtronic PLC
CapsoVision Inc.
IntroMedic
Olympus Medical Technology
Jinshan Science and Technology
etectRx Inc.
Medisafe
HQ, Inc
Check-Cap

Recent Developments:

United States:
Eli Lilly: In April 2025, Eli Lilly announced promising trial data for orforglipron, a new oral GLP-1 drug for weight loss and diabetes management, potentially transforming obesity treatment .

Novo Nordisk: In May 2024, Novo Nordisk requested permission from the US FDA for an oral form of its weight-loss medicine Wegovy, with the goal of expanding obesity treatment choices.

Japan:
In December 2024, RF Co., Ltd. unveiled an enhanced capsule endoscopy system that offers improved diagnostic accuracy for gastrointestinal disorders.
In January 2025, Otsuka Holdings Co., Ltd. introduced a smart tablet designed for targeted drug delivery, marking a major advancement in personalized treatment for chronic diseases.

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Conclusion:

The smart pills market is on the cusp of significant growth, driven by technological innovations and an increasing demand for non-invasive, personalized healthcare solutions. As the industry continues to evolve, stakeholders are encouraged to stay abreast of developments to capitalize on emerging opportunities.

Related Reports:

Decentralized Clinical Trials Market

AI in Precision Medicine Market

Sai Kiran
DataM Intelligence 4Market Research
+1 877-441-4866
email us here
Visit us on social media:
LinkedIn
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.